1. Home
  2. IMNM vs HLF Comparison

IMNM vs HLF Comparison

Compare IMNM & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • HLF
  • Stock Information
  • Founded
  • IMNM 2006
  • HLF 1980
  • Country
  • IMNM United States
  • HLF United States
  • Employees
  • IMNM N/A
  • HLF N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • HLF Other Pharmaceuticals
  • Sector
  • IMNM Health Care
  • HLF Health Care
  • Exchange
  • IMNM Nasdaq
  • HLF Nasdaq
  • Market Cap
  • IMNM 945.8M
  • HLF 854.5M
  • IPO Year
  • IMNM 2020
  • HLF N/A
  • Fundamental
  • Price
  • IMNM $10.60
  • HLF $9.22
  • Analyst Decision
  • IMNM Strong Buy
  • HLF Strong Buy
  • Analyst Count
  • IMNM 5
  • HLF 4
  • Target Price
  • IMNM $26.40
  • HLF $11.50
  • AVG Volume (30 Days)
  • IMNM 965.4K
  • HLF 1.8M
  • Earning Date
  • IMNM 08-11-2025
  • HLF 08-06-2025
  • Dividend Yield
  • IMNM N/A
  • HLF N/A
  • EPS Growth
  • IMNM N/A
  • HLF 100.43
  • EPS
  • IMNM N/A
  • HLF 2.74
  • Revenue
  • IMNM $10,938,000.00
  • HLF $4,950,500,000.00
  • Revenue This Year
  • IMNM N/A
  • HLF $0.10
  • Revenue Next Year
  • IMNM $259.34
  • HLF $4.12
  • P/E Ratio
  • IMNM N/A
  • HLF $3.44
  • Revenue Growth
  • IMNM N/A
  • HLF N/A
  • 52 Week Low
  • IMNM $5.15
  • HLF $5.04
  • 52 Week High
  • IMNM $16.81
  • HLF $12.79
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 60.20
  • HLF 47.68
  • Support Level
  • IMNM $10.33
  • HLF $9.66
  • Resistance Level
  • IMNM $11.08
  • HLF $10.14
  • Average True Range (ATR)
  • IMNM 0.60
  • HLF 0.50
  • MACD
  • IMNM 0.04
  • HLF -0.13
  • Stochastic Oscillator
  • IMNM 72.31
  • HLF 8.22

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About HLF Herbalife Ltd.

Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.

Share on Social Networks: